GBS Foundation
Home
You Are Not Alone.
The GBS Foundation-Kenya is at the center of the care ecosystem, bringing patients, healthcare professionals, government, industry and other stakeholders together to improve outcomes by enhancing awareness, patient support, and access to timely and affordable treatment for people affected by GBS, CIDP and associated neuropathies.
Everyone Has a Role
There is a place for you in the pursuit of better outcomes across the patient care journey.
Patients
Your experience matters. Connect with others, access support and information, and help ensure that the voices and experiences of people living with GBS, CIDP and associated neuropathies remain at the centre of the conversation.
Join Our Community →Caregivers & Families
You don't have to navigate the journey alone. Find practical information, support resources and guidance for supporting someone affected by GBS, CIDP and associated neuropathies.
Find Support →Healthcare Professionals
Help strengthen recognition and care. Join opportunities for knowledge exchange and professional collaboration aimed at improving recognition, diagnosis, referral and care.
Work With Us →Healthcare Institutions & Industry Partners
Help build a stronger care ecosystem. Partner with us to advance awareness, strengthen patient support and improve access to timely and affordable treatment.
Partner With Us →Understanding the Conditions
Awareness is the first step towards better care
GBS, CIDP and associated neuropathies affect the peripheral nervous system and can significantly impact movement, sensation and everyday life.

Guillain-Barré Syndrome (GBS)
GBS is an inflammatory disorder of the peripheral nerves, the nerves outside the brain and spinal cord. It is characterised by the rapid onset of weakness and can cause paralysis affecting the legs, arms, breathing muscles and face. Abnormal sensations may also accompany the weakness.
Learn More →
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CIDP is a rare disorder of the peripheral nerves characterised by gradually increasing weakness and sensory loss, often accompanied by loss of reflexes. Unlike GBS, which typically reaches maximum weakness within days or weeks, CIDP progresses over a longer period.
Learn More →
Associated Neuropathies
The Foundation also works to improve awareness and support for other neuropathies associated with the GBS/CIDP spectrum, including Multifocal Motor Neuropathy (MMN), Acute Motor Axonal Neuropathy (AMAN) and Miller Fisher Syndrome.
Explore Neuropathies →OUR WORK IN PERSPECTIVE
Building a Stronger Care Ecosystem
Our work is focused on raising awareness, providing patient and caregiver support, and advocating for improved access to treatment and quality healthcare.
